CoChat

Early phase trials of novel hearing therapeutics: Avenues and opportunities

Schilder, Anne G.M., Su, Matthew P., Mandavia, Rishi, Anderson, Caroline R., Landry, Evie, Ferdous, Tanjinah, Blackshaw, Helen · 2019 · Hearing Research
Cited by 19

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.heares.2019.07.003

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 154

  1. Abou Tayoun, 2016, Improving hearing loss gene testing: a systematic review of gene evidence toward more efficient next-generation sequencing–based diagnostic testing and interpretation, Genet. Med., 18, 545, 10.1038/gim.2015.141 · DOI
  2. Abt, 2016, Intratympanic iodine contrast injection diffuses across the round window membrane allowing for perilymphatic CT volume Acquisition imaging, Otol. Neurotol., 37, 403, 10.1097/MAO.0000000000000974 · doi:10.1097/mao.0000000000000974
  3. Ahmed, 2017, Emerging gene therapies for genetic hearing loss, JARO J. Assoc. Res. Otolaryngol., 10.1007/s10162-017-0634-8 · DOI
  4. Araya-Secchi, 2016, An elastic element in the protocadherin-15 tip link of the inner ear, Nat. Commun., 10.1038/ncomms13458 · DOI
  5. Atkinson, 2015, Sensory hair cell development and regeneration: similarities and differences, Development, 142, 1561, 10.1242/dev.114926 · DOI
  6. Bai, 1997, Mitochondrial DNA deletions associated with aging and possibly presbycusis: a human archival temporal bone study, Am. J. Otol., 18, 449
  7. Bakay, 2018, Hidden hearing loss selectively impairs neural adaptation to loud sound environments, Nat. Commun., 9, 4298, 10.1038/s41467-018-06777-y · doi:10.1038/s41467-018-06777-y
  8. Barczik, 2018, Accuracy of smartphone self-hearing test applications across frequencies and earphone styles in adults, Am. J. Audiol., 1
  9. Bas, 2016, Electrode array-eluted dexamethasone protects against electrode insertion trauma induced hearing and hair cell losses, damage to neural elements, increases in impedance and fibrosis: a dose response study, Hear. Res., 337, 12, 10.1016/j.heares.2016.02.003 · DOI
  10. Bitner-Glindzicz, 2002, Hereditary deafness and phenotyping in humans, Br. Med. Bull., 63, 73, 10.1093/bmb/63.1.73 · DOI · Paper page
  11. Bognar, 2017, The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions, J. Health Econ., 10.1016/j.jhealeco.2016.12.001 · DOI
  12. Borenstein, 2009, Flexible microsystems deliver drugs through the ear [WWW document], IEEE Spectr. Technol. Eng. Sci. News
  13. Böttger, 2013, The mitochondrion: a perpetrator of acquired hearing loss, Hear. Res., 10.1016/j.heares.2013.01.006 · DOI · Paper page
  14. Brock, 2016, Two-year results of clinical efficacy of cisplatin in combination with sodium thiosulfate (STS) vs cisplatin alone in a randomized phase III trial for standard risk hepatoblastoma (SR-HB): SIOPEL 6, J. Clin. Oncol., 34, 10514, 10.1200/JCO.2016.34.15_suppl.10514 · doi:10.1200/jco.2016.34.15_suppl.10514
  15. Brock, 2018, Sodium thiosulfate for protection from cisplatin-induced hearing loss, N. Engl. J. Med., 378, 2376, 10.1056/NEJMoa1801109 · DOI · Paper page
  16. Budenz, 2015, Differential effects of AAV.BDNF and AAV.Ntf3 in the deafened adult Guinea pig ear, Sci. Rep., 5, 8619, 10.1038/srep08619 · doi:10.1038/srep08619
  17. Burgansky-Eliash, 2005, Optical coherence tomography machine learning classifiers for glaucoma detection: a preliminary study, Investig. Opthalmology Vis. Sci., 46, 4147, 10.1167/iovs.05-0366 · DOI · Paper page
  18. Campbell, 2016, Guidelines for auditory threshold measurement for significant threshold shift, Otol. Neurotol., 37, e263, 10.1097/MAO.0000000000001135 · doi:10.1097/mao.0000000000001135
  19. Chiu, 2008, Using the zebrafish lateral line to screen for ototoxicity, JARO J. Assoc. Res. Otolaryngol., 10.1007/s10162-008-0118-y · doi:10.1007/s10162-008-0118-y
  20. Christie, 2014, Noise-induced hearing loss: new animal models, Curr. Opin. Otolaryngol. Head Neck Surg., 10.1097/MOO.0000000000000086 · DOI
  21. Crowson, 2017, Emerging therapies for sensorineural hearing loss, Otol. Neurotol., 38, 792, 10.1097/MAO.0000000000001427 · DOI
  22. Denayer, 2014, Animal models in translational medicine: validation and prediction, New Horizons Transl. Med
  23. Edvardsson Rasmussen, 2018, The proteome of perilymph in patients with vestibular schwannoma. A possibility to identify biomarkers for tumor associated hearing loss?, PLoS One, 13, 10.1371/journal.pone.0198442 · DOI
  24. Emptoz, 2017, Local gene therapy durably restores vestibular function in a mouse model of Usher syndrome type 1G, Proc. Natl. Acad. Sci., 10.1073/pnas.1708894114 · DOI
  25. Fischel-Ghodsian, 1997, Temporal bone analysis of patients with presbycusis reveals high frequency of mitochondrial mutations, Hear. Res., 110, 147, 10.1016/S0378-5955(97)00077-4 · DOI
  26. Frisina, 2018, Animal model studies yield translational solutions for cochlear drug delivery, Hear. Res., 10.1016/j.heares.2018.05.002 · DOI
  27. Gao, 2017, Mitochondrial DNA mutations associated with aminoglycoside induced ototoxicity, J. Otolaryngol.
  28. Gehrke, 2016, Ear Cubes for local controlled drug delivery to the inner ear, Int. J. Pharm., 509, 85, 10.1016/j.ijpharm.2016.04.003 · doi:10.1016/j.ijpharm.2016.04.003
  29. Granberg, 2014, The ICF core sets for hearing loss - researcher perspective. Part I: systematic review of outcome measures identified in audiological research, Int. J. Audiol.
  30. Guest, 2018, Impaired speech perception in noise with a normal audiogram: No evidence for cochlear synaptopathy and no relation to lifetime noise exposure, Hear. Res., 10.1016/j.heares.2018.03.008 · DOI · Paper page
  31. Gurman, 2015, Clinical applications of biomedical microdevices for controlled drug delivery, Mayo Clin. Proc., 90, 93, 10.1016/j.mayocp.2014.10.003 · DOI
  32. Hall, 2016, Systematic review of outcome domains and instruments used in clinical trials of tinnitus treatments in adults, Trials, 10.1186/s13063-016-1399-9 · DOI · Paper page
  33. Hall, 2018, The COMiT’ID study: developing Core Outcome Domains Sets for clinical trials of sound-, psychology-, and pharmacology-based interventions for chronic subjective tinnitus in adults, Trends. Hear, 10.1177/2331216518814384 · DOI
  34. Hams, 2017, Otoferlin is a multivalent calcium-sensitive scaffold linking SNAREs and calcium channels, Proc. Natl. Acad. Sci., 10.1073/pnas.1703240114 · DOI
  35. Hana, 2018, Prestin, otolin-1 regulation, and human 8-oxoG DNA glycosylase 1 gene polymorphisms in noise-induced hearing loss, Ibnosina J. Med. Biomed. Sci.
  36. Hemingway, 2017, Programme Grants Appl. Res., 5, 1, 10.3310/pgfar05040 · DOI
  37. Hickox, 2017, Translational issues in cochlear synaptopathy, Hear. Res., 349, 164, 10.1016/j.heares.2016.12.010 · doi:10.1016/j.heares.2016.12.010
  38. Hildebrand, 2009, A Contemporary Review of AudioGene audioprofiling: a machine-based candidate gene prediction tool for autosomal dominant nonsyndromic hearing loss, The Laryngoscope, 119, 2211, 10.1002/lary.20664 · doi:10.1002/lary.20664
  39. Hildebrand, 2008, Audioprofile-directed screening identifies novel mutations in KCNQ4 causing hearing loss at the DFNA2 locus, Genet. Med., 10, 797, 10.1097/GIM.0b013e318187e106 · doi:10.1097/gim.0b013e318187e106
  40. Hollingworth, 2017, A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015, BMJ Open, 7, 10.1136/bmjopen-2017-018289 · DOI
  41. Hütten, 2014, In vitro and in vivo evaluation of a hydrogel reservoir as a continuous drug delivery system for inner ear treatment, PLoS One, 9, 10.1371/journal.pone.0104564 · DOI
  42. IJzerman, 2017, Emerging use of early health technology assessment in medical product development: a scoping review of the literature, Pharmacoeconomics, 35, 727, 10.1007/s40273-017-0509-1 · DOI · Paper page
  43. IJzerman, 2011, Early assessment of medical technologies to inform product development and market access, Appl. Health Econ. Health Policy, 9, 331, 10.2165/11593380-000000000-00000 · DOI · Paper page
  44. Isgrig, 2017, Gene therapy restores balance and auditory functions in a mouse model of usher syndrome, Mol. Ther., 10.1016/j.ymthe.2017.01.007 · DOI · Paper page
  45. Iyer, 2016, Micro-optical coherence tomography of the mammalian cochlea, Sci. Rep., 6, 33288, 10.1038/srep33288 · doi:10.1038/srep33288
  46. Jahnke, 1980, The blood-perilymph barrier, Arch. Oto-Rhino-Laryngol., 228, 29, 10.1007/BF00455891 · DOI
  47. Jeong, 2018, Generating inner ear organoids containing putative cochlear hair cells from human pluripotent stem cells, Cell Death Dis., 10.1038/s41419-018-0967-1 · DOI
  48. Jolly, 2010, Electrode features for hearing preservation and drug delivery strategies, Adv. Oto-Rhino-Laryngol., 67, 28, 10.1159/000262594 · doi:10.1159/000262594
  49. Justicia-Grande, 2016, Development and validation of a new clinical scale for infants with acute respiratory infection: the ReSVinet scale, PLoS One, 11, 10.1371/journal.pone.0157665 · DOI
  50. Kamitani, 2015, Deletion of tricellulin causes progressive hearing loss associated with degeneration of cochlear hair cells, Sci. Rep., 10.1038/srep18402 · DOI
  51. Kazmierczak, 2015, Progressive hearing loss in mice carrying a mutation in Usp53, J. Neurosci., 10.1523/JNEUROSCI.1965-15.2015 · DOI
  52. Lanvers-Kaminsky, 2017, Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin, Pharmacogenomics, 18, 1683, 10.2217/pgs-2017-0125 · DOI
  53. Le Prell, 2016, Speech-in-Noise tests and supra-threshold auditory evoked potentials as metrics for noise damage and clinical trial outcome measures, Otol. Neurotol., 10.1097/MAO.0000000000001069 · doi:10.1097/mao.0000000000001069
  54. Le Prell, 2017, Effects of noise on speech recognition: challenges for communication by service members, Hear. Res., 349, 76, 10.1016/j.heares.2016.10.004 · doi:10.1016/j.heares.2016.10.004
  55. Le Prell, 2016, Dietary supplement comprised of β-carotene, vitamin C, vitamin E, and magnesium: failure to prevent music-induced temporary threshold shift, Audiol. Neurotol. Extra, 10.1159/000446600 · DOI
  56. Le, 2017, Current insights in noise-induced hearing loss: a literature review of the underlying mechanism, pathophysiology, asymmetry, and management options, J. Otolaryngol. Head Neck Surg., 10.1186/s40463-017-0219-x · DOI · Paper page
  57. Lee, 2018, Circulating serum miRNA-205 as a diagnostic biomarker for ototoxicity in mice treated with aminoglycoside antibiotics, Int. J. Mol. Sci., 19, 2836, 10.3390/ijms19092836 · doi:10.3390/ijms19092836
  58. Lenarz, 2017, Cochlear implant - state of the art, GMS Curr. Top. Otorhinolaryngol., Head Neck Surg., 16, Doc04
  59. Li, 2016, Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research?, J. Clin. Epidemiol., 80, 16, 10.1016/j.jclinepi.2016.08.003 · DOI · Paper page
  60. Li, 2018, Using Drosophila to study mechanisms of hereditary hearing loss, Dis. Model. Mech., 10.1242/dmm.031492 · DOI
  61. Li, 2018, Permeation enhancers for intratympanically-applied drugs studied using fluorescent dexamethasone as a marker: otol, Neurotol, 39, 639, 10.1097/MAO.0000000000001786 · DOI
  62. Li, 2015, Notch inhibition induces mitotically generated hair cells in mammalian cochleae via activating the Wnt pathway, Proc. Natl. Acad. Sci.
  63. Li, 2018, Analysis of serum microRNA expression in male workers with occupational noise-induced hearing loss, Brazilian J. Med. Biol. Res., 51, 10.1590/1414-431x20176426 · DOI
  64. Liba, 2017, Changes in serum prestin concentration after exposure to cisplatin, Otol. Neurotol., 38, 10.1097/MAO.0000000000001616 · doi:10.1097/mao.0000000000001616
  65. Libé-Philippot, 2017, Auditory cortex interneuron development requires cadherins operating hair-cell mechanoelectrical transduction, Proc. Natl. Acad. Sci., 10.1073/pnas.1703408114 · DOI
  66. Liberman, 2016, Toward a differential diagnosis of hidden hearing loss in humans, PLoS One, 10.1371/journal.pone.0162726 · DOI · Paper page
  67. Liu, 2014, Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing, Drug Dev. Ind. Pharm., 40, 896, 10.3109/03639045.2013.789054 · DOI
  68. Livingston, 2017, Dementia prevention, intervention, and care, Lancet, 10.1016/S0140-6736(17)31363-6 · DOI · Paper page
  69. Lobarinas, 2013, Insensitivity of the audiogram to carboplatin induced inner hair cell loss in chinchillas, Hear. Res., 10.1016/j.heares.2013.03.012 · DOI · Paper page
  70. Looi, 2015, Hearing loss: a global health issue, Lancet, 10.1016/S0140-6736(15)60208-2 · doi:10.1016/s0140-6736(15)60208-2
  71. López-López, 2017, Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis, BMJ, 10.1136/bmj.j5058 · DOI · Paper page
  72. Lustig, 2012, Cochlear gene therapy, Curr. Opin. Neurol., 25, 57, 10.1097/WCO.0b013e32834f038c · doi:10.1097/wco.0b013e32834f038c
  73. Lysaght, 2011, Proteome of human perilymph, J. Proteome Res., 10, 3845, 10.1021/pr200346q · DOI
  74. Mahomed-Asmail, 2016, Clinical validity of hearScreenTM smartphone hearing screening for School children, Ear Hear., 37, e11, 10.1097/AUD.0000000000000223 · DOI
  75. Mak, 2014, Lost in translation: animal models and clinical trials in cancer treatment, Am. J. Transl. Res., 6, 114
  76. Mandavia, 2017, What are the essential features of a successful surgical registry? a systematic review, BMJ Open, 10.1136/bmjopen-2017-017373 · DOI
  77. Mariano, 2011, A look at tricellulin and its role in tight junction formation and maintenance, Eur. J. Cell Biol.
  78. Markaryan, 2010, Major arc mitochondrial DNA deletions in cytochrome c oxidase-deficient human cochlear spiral ganglion cells, Acta Otolaryngol., 130, 780, 10.3109/00016480903397702 · DOI
  79. Marsella, 2017, EEG activity as an objective measure of cognitive load during effortful listening: a study on pediatric subjects with bilateral, asymmetric sensorineural hearing loss, Int. J. Pediatr. Otorhinolaryngol., 10.1016/j.ijporl.2017.05.006 · DOI · Paper page
  80. Mazur, 2018, The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates, Lancet Infect. Dis., 18, e295, 10.1016/S1473-3099(18)30292-5 · DOI · Paper page
  81. McLean, 2017, Clonal expansion of Lgr5-positive cells from mammalian cochlea and high-purity generation of sensory hair cells HHS public access, Cell Rep., 10.1016/j.celrep.2017.01.066 · DOI · Paper page
  82. Michalski, 2017, Otoferlin acts as a Ca2+ sensor for vesicle fusion and vesicle pool replenishment at auditory hair cell ribbon synapses, Elife, 6, 10.7554/eLife.31013 · DOI
  83. Milner, 2018, Abnormal resting-state quantitative electroencephalogram in children with central auditory processing disorder: a pilot study, Front. Neurosci., 10.3389/fnins.2018.00292 · DOI
  84. Mittal, 2017, Recent advancements in the regeneration of auditory hair cells and hearing restoration, Front. Mol. Neurosci., 10, 236, 10.3389/fnmol.2017.00236 · DOI
  85. Mizutari, 2013, Notch inhibition induces cochlear hair cell regeneration and recovery of hearing after acoustic trauma, Neuron, 77, 58, 10.1016/j.neuron.2012.10.032 · DOI · Paper page
  86. Moore, 2004, New version of the TEN test with calibrations in dB HL, Ear Hear., 25, 478, 10.1097/01.aud.0000145992.31135.89 · doi:10.1097/01.aud.0000145992.31135.89
  87. Müller, 2015, New treatment options for hearing loss, Nat. Rev. Drug Discov., 10.1038/nrd4533 · DOI · Paper page
  88. Myint, 2016, Large-scale phenotyping of noise-induced hearing loss in 100 strains of mice, Hear. Res., 332, 113, 10.1016/j.heares.2015.12.006 · DOI
  89. Nakagawa, 2014, Strategies for developing novel therapeutics for sensorineural hearing loss, Front. Pharmacol., 5, 206, 10.3389/fphar.2014.00206 · DOI
  90. Naples, 2018, Prestin as an otologic biomarker of cisplatin ototoxicity in a Guinea pig model, Otolaryngol. Neck Surg., 158, 541, 10.1177/0194599817742093 · doi:10.1177/0194599817742093
  91. Nguyen, 2017, Expert opinion on therapeutic patents, Expert Opin. Ther. Pat., 27, 191, 10.1080/13543776.2017.1252751 · DOI
  92. Nist-Lund, 2019, Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders, Nat. Commun., 10
  93. Okano, 2014, Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss, Front. Pharmacol., 10.3389/fphar.2014.00205 · DOI
  94. Ou, 2010, Drug screening for hearing loss: using the zebrafish lateral line to screen for drugs that prevent and cause hearing loss, Drug Discov. Today, 10.1016/j.drudis.2010.01.001 · DOI
  95. Pang, 2016, Circulating miR-34a levels correlate with age-related hearing loss in mice and humans, Exp. Gerontol., 76, 58, 10.1016/j.exger.2016.01.009 · DOI
  96. Parham, 2016, Outer hair cell molecular protein, prestin, as a serum biomarker for hearing loss, Otol. Neurotol., 37, 1217, 10.1097/MAO.0000000000001164 · DOI
  97. Parham, 2014, Inner ear protein as a biomarker in circulation?, Otolaryngol. Neck Surg., 151, 1038, 10.1177/0194599814551127 · doi:10.1177/0194599814551127
  98. Parham, 2019, Noise-induced trauma produces a temporal pattern of change in blood levels of the outer hair cell biomarker prestin, Hear. Res., 371, 98, 10.1016/j.heares.2018.11.013 · DOI
  99. Peppi, 2018, Intracochlear drug delivery systems a novel approach whose time has come, Expert Opin. Drug Deliv., 15, 319, 10.1080/17425247.2018.1444026 · DOI
  100. Petit, 2009, Linking genes underlying deafness to hair-bundle development and function, Nat. Neurosci., 10.1038/nn.2330 · DOI · Paper page
  101. Pinyon, 2018, Dual-plasmid bionic array-directed gene electrotransfer in HEK293 cells and cochlear mesenchymal cells probes transgene expression and cell fate, Hum. Gene Ther. Hum., 062
  102. Pinyon, 2014, Close-field electroporation gene delivery using the cochlear implant electrode array enhances the bionic ear, Sci. Transl. Med., 6, 233ra54, 10.1126/scitranslmed.3008177 · DOI · Paper page
  103. Piquado, 2010, Pupillometry as a measure of cognitive effort in younger and older adults, Psychophysiology, 47, 560, 10.1111/j.1469-8986.2009.00947.x · DOI · Paper page
  104. Plack, 2016, Toward a diagnostic test for hidden hearing loss, Trends. Hear, 20
  105. Plantinga, 2005, Serial audiometry and speech recognition findings in Finnish Usher syndrome type III patients, Audiol. Neuro. Otol., 10, 79, 10.1159/000083363 · doi:10.1159/000083363
  106. Plontke, 2014, Controlled release dexamethasone implants in the round window niche for salvage treatment of idiopathic sudden sensorineural hearing loss, Otol. Neurotol., 35, 1168, 10.1097/MAO.0000000000000434 · DOI
  107. Plontke, 2017, Intracochlear drug delivery in combination with cochlear implants Current aspects, HNO, 65, 19, 10.1007/s00106-016-0285-9 · DOI
  108. Plontke, 2016, Intracochlear drug injections through the round window membrane: measures to improve drug retention, Audiol. Neuro. Otol., 21, 72, 10.1159/000442514 · doi:10.1159/000442514
  109. Plontke, 2007, Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model, Audiol. Neuro. Otol., 12, 37, 10.1159/000097246 · DOI
  110. Plontke, 2006, Technical note on microcatheter implantation for local inner ear drug delivery: surgical technique and safety aspects, Otol. Neurotol. Off. Publ. Am. Otol. Soc. Am. Neurotol. Soc. Eur. Acad. Otol. Neurotol., 27, 912, 10.1097/01.mao.0000235310.72442.4e · DOI
  111. Pyykkö, 2011, Nanoparticle-based delivery for the treatment of inner ear disorders, Curr. Opin. Otolaryngol. Head Neck Surg., 10.1097/MOO.0b013e32834aa3a8 · DOI
  112. Qian, 2009, Interaction of aminoglycosides with human mitochondrial 12S rRNA carrying the deafness-associated mutation, Antimicrob. Agents Chemother., 10.1128/AAC.00965-08 · DOI
  113. Rivolta, 2002, Cell lines in inner ear research, J. Neurobiol., 10.1002/neu.10111 · doi:10.1002/neu.10111
  114. Rodríguez-Ballesteros, 2008, A multicenter study on the prevalence and spectrum of mutations in the otoferlin gene ( OTOF ) in subjects with nonsyndromic hearing impairment and auditory neuropathy, Hum. Mutat., 29, 823, 10.1002/humu.20708 · DOI · Paper page
  115. Roemer, 2016, Biohybrid cochlear implants in human neurosensory restoration, Stem Cell Res. Ther., 7, 148, 10.1186/s13287-016-0408-y · DOI
  116. Rourke, 2016, Tablet audiometry in Canada's North, Otolaryngol. Neck Surg., 155, 473, 10.1177/0194599816644407 · doi:10.1177/0194599816644407
  117. Rudman, 2018, Precision medicine in hearing loss, J. Genet. Genomics, 45, 99, 10.1016/j.jgg.2018.02.004 · DOI
  118. Rüttiger, 2017, Biomarkers for hearing dysfunction: facts and outlook, ORL. J. Otorhinolaryngol. Relat. Spec., 79, 93, 10.1159/000455705 · DOI
  119. Ryu, 2016, Screening of the SLC17A8 gene as a causative factor for autosomal dominant non-syndromic hearing loss in Koreans, BMC Med. Genet., 10.1186/s12881-016-0269-3 · doi:10.1186/s12881-016-0269-3
  120. Salt, 2018, Communication pathways to and from the inner ear and their contributions to drug delivery, Hear. Res., 362, 25, 10.1016/j.heares.2017.12.010 · DOI · Paper page
  121. Salt, 2018, Pharmacokinetic principles in the inner ear: influence of drug properties on intratympanic applications, Hear. Res., 10.1016/j.heares.2018.03.002 · DOI · Paper page
  122. Salt, 2009, Principles of local drug delivery to the inner ear, Audiol. Neurotol., 10.1159/000241892 · DOI · Paper page
  123. Salt, 2007, Marker retention in the cochlea following injections through the round window membrane, Hear. Res., 232, 78, 10.1016/j.heares.2007.06.010 · doi:10.1016/j.heares.2007.06.010
  124. Schaette, 2011, Tinnitus with a normal audiogram: physiological evidence for hidden hearing loss and computational model, J. Neurosci., 31, 13452, 10.1523/JNEUROSCI.2156-11.2011 · DOI · Paper page
  125. Schilder, 2018, Biological therapies of the inner ear: what otologists need to consider, Otol. Neurotol., 10.1097/MAO.0000000000001689 · doi:10.1097/mao.0000000000001689
  126. Schilder, 2019, Hearing protection, restoration and regeneration: an overview of emerging therapeutics for inner ear and central hearing disorders, Otol. Neurotol., 40, 559, 10.1097/MAO.0000000000002194 · DOI
  127. Schmitt, 2018, Heat shock proteins in human perilymph, Otol. Neurotol., 39, 37, 10.1097/MAO.0000000000001625 · DOI
  128. Schmitt, 2017, Proteome analysis of human perilymph using an intraoperative sampling method, J. Proteome Res., 16, 1911, 10.1021/acs.jproteome.6b00986 · DOI
  129. Schulze, 2018, Microenvironmental support for cell delivery to the inner ear, Hear. Res., 10.1016/j.heares.2018.06.015 · DOI
  130. Shalaby, 2016, Licence to save: a UK survey of anti-VEGF use for the eye in 2015, Eye (Lond)., 30, 1404, 10.1038/eye.2016.154 · DOI
  131. Shapiro, 2014, Shaping magnetic fields to direct therapy to ears and eyes, Annu. Rev. Biomed. Eng., 16, 455, 10.1146/annurev-bioeng-071813-105206 · DOI
  132. Shen, 2016, Using cognitive screening tests in Audiology, Am. J. Audiol., 25, 319, 10.1044/2016_AJA-16-0032 · DOI
  133. Shew, 2018, Feasibility of microRNA profiling in human inner ear perilymph, Neuroreport, 29, 894, 10.1097/WNR.0000000000001049 · DOI
  134. Smith, 2018, ENT audit and research in the era of trainee collaboratives, Eur. Arch. Oto-Rhino-Laryngol., 275, 1935, 10.1007/s00405-018-5009-1 · doi:10.1007/s00405-018-5009-1
  135. Suzuki, 2017, Cochlear gene therapy with ancestral AAV in adult mice: complete transduction of inner hair cells without cochlear dysfunction, Sci. Rep., 7, 45524, 10.1038/srep45524 · DOI · Paper page
  136. Takeda, 2018, Challenges in cell-based therapies for the treatment of hearing loss, Trends Neurosci., 41, 823, 10.1016/j.tins.2018.06.008 · DOI
  137. Tandon, 2015, Microfabricated infuse-withdraw micropump component for an integrated inner-ear drug-delivery platform, Biomed. Microdevices, 17, 37, 10.1007/s10544-014-9923-8 · DOI
  138. Taylor, 2018, Regenerating hair cells in vestibular sensory epithelia from humans, Elife, 10.7554/eLife.34817.016 · doi:10.7554/elife.34817.016
  139. Taylor, 2015, Characterizing human vestibular sensory epithelia for experimental studies: new hair bundles on old tissue and implications for therapeutic interventions in ageing, Neurobiol. Aging, 10.1016/j.neurobiolaging.2015.02.013 · doi:10.1016/j.neurobiolaging.2015.02.013
  140. van Beelen, 2016, Audiometric characteristics of a Dutch DFNA10 family with mid-frequency hearing impairment, Ear Hear., 37, 103, 10.1097/AUD.0000000000000217 · doi:10.1097/aud.0000000000000217
  141. van Loon, 2013, Spiral ganglion cell morphology in Guinea pigs after deafening and neurotrophic treatment, Hear. Res., 298, 17, 10.1016/j.heares.2013.01.013 · DOI
  142. Vona, 2015, Non-syndromic hearing loss gene identification: a brief history and glimpse into the future, Mol. Cell. Probes, 29, 260, 10.1016/j.mcp.2015.03.008 · DOI
  143. Wang, 2016, An in vivo pharmacological screen identifies cholinergic signaling as a therapeutic target in glial-based nervous system disease, J. Neurosci., 10.1523/JNEUROSCI.0256-15.2016 · DOI
  144. Whitlon, 2017, Drug discovery for hearing loss: phenotypic screening of chemical compounds on primary cultures of the spiral ganglion, Hear. Res., 10.1016/j.heares.2016.07.019 · DOI
  145. Wong, 2018, Inner ear exosomes and their potential use as biomarkers, PLoS One, 13, 10.1371/journal.pone.0198029 · DOI
  146. Wong, 2016, Artificial intelligence with deep learning technology looks into diabetic retinopathy screening, JAMA, 316, 2366, 10.1001/jama.2016.17563 · DOI · Paper page
  147. Wu, 2016, Co-regulation of the Notch and Wnt signaling pathways promotes supporting cell proliferation and hair cell regeneration in mouse utricles, Sci. Rep.
  148. Yadav, 2016, Cancer drug development using Drosophila as an in vivo tool: from bedside to bench and back, Trends Pharmacol. Sci., 10.1016/j.tips.2016.05.010 · DOI
  149. Yamasoba, 2013, Current concepts in age-related hearing loss: epidemiology and mechanistic pathways, Hear. Res., 10.1016/j.heares.2013.01.021 · DOI · Paper page
  150. Yano, 2014, Frequency of mitochondrial mutations in non-syndromic hearing loss as well as possibly responsible variants found by whole mitochondrial genome screening, J. Hum. Genet., 10.1038/jhg.2013.128 · doi:10.1038/jhg.2013.128
  151. Ye, 2007, Application of a corticosteroid (triamcinolon) protects inner ear function after surgical intervention, Ear Hear., 28, 361, 10.1097/01.aud.0000261655.30652.62 · DOI
  152. Yoshimura, 2018, Enhanced viral-mediated cochlear gene delivery in adult mice by combining canal fenestration with round window membrane inoculation, Sci. Rep., 10.1038/s41598-018-21233-z · DOI · Paper page
  153. Zeng, 2018, Screen for modulators of atonal homolog 1 gene expression using notch pathway-relevant gene transcription based cellular assays, PLoS One, 13, 10.1371/journal.pone.0207140 · doi:10.1371/journal.pone.0207140
  154. Zou, 2015, Micro CT visualization of silver nanoparticles in the middle and inner ear of rat and transportation pathway after transtympanic injection, J. Nanobiotechnol., 13, 5, 10.1186/s12951-015-0065-9 · doi:10.1186/s12951-015-0065-9

Cited by

See all 19

Metadata

Authors
Schilder, A. G. M., Su, M. P., Mandavia, R., Anderson, C. R., Landry, E., Ferdous, T., & Blackshaw, H.
Venue
Hearing Research
Publisher
Elsevier BV
Published
2019-09
Volume
380
Pages
175-186
ISSN
0378-5955
Cited by
19
References
6
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Collaboration for Leadership in Applied Health Research and Care - Greater Manchester
  • National Institute for Health Research
  • UCLH Biomedical Research Centre

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.